Xenon Pharmaceuticals Net Non-Operating Interest Income Expense (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

42.15 +0.93 (+2.26%) USD | NASDAQ | Jan 09, 16:00

42.16 0.00 (0.00%) After-Hours: 20:00

View Net Non-Operating Interest Income Expense (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	Upgrade
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	Upgrade
ProMIS Neurosciences, Inc.	Upgrade